Takeda Pharmaceutical Company Limited
Assays for determining plasma kallikrein system biomarkers

Abstract:

Methods and assays for determining the activation level of the plasma kallikrein (pKal) system and the uses thereof for assessing the activity of pKal modulators on the pKal system.